335 related articles for article (PubMed ID: 31048856)
21. Stroke Exacerbates Cancer Progression by Upregulating LCN2 in PMN-MDSC.
Huang T; Li Y; Zhou Y; Lu B; Zhang Y; Tang D; Gan Y; He Z; Chen Z; Yu W; Li P
Front Immunol; 2020; 11():299. PubMed ID: 32153594
[TBL] [Abstract][Full Text] [Related]
22. Phenotypic and transcriptomic characterization of canine myeloid-derived suppressor cells.
Goulart MR; Hlavaty SI; Chang YM; Polton G; Stell A; Perry J; Wu Y; Sharma E; Broxholme J; Lee AC; Szladovits B; Turmaine M; Gribben J; Xia D; Garden OA
Sci Rep; 2019 Mar; 9(1):3574. PubMed ID: 30837603
[TBL] [Abstract][Full Text] [Related]
23. Myeloid-derived suppressor cell functionality and interaction with Leishmania major parasites differ in C57BL/6 and BALB/c mice.
Schmid M; Zimara N; Wege AK; Ritter U
Eur J Immunol; 2014 Nov; 44(11):3295-306. PubMed ID: 25142017
[TBL] [Abstract][Full Text] [Related]
24. Heat-killed Mycobacterium tuberculosis prime-boost vaccination induces myeloid-derived suppressor cells with spleen dendritic cell-killing capability.
Ribechini E; Eckert I; Beilhack A; Du Plessis N; Walzl G; Schleicher U; Ritter U; Lutz MB
JCI Insight; 2019 Jun; 5(13):. PubMed ID: 31162143
[TBL] [Abstract][Full Text] [Related]
25. The spleen contributes to the increase in PMN-MDSCs in orthotopic H22 hepatoma mice.
Li BH; Jiang W; Zhang S; Huang N; Sun J; Yang J; Li ZF
Mol Immunol; 2020 Sep; 125():95-103. PubMed ID: 32659598
[TBL] [Abstract][Full Text] [Related]
26. Human splenic myeloid derived suppressor cells: Phenotypic and clustering analysis.
Cole KE; Ly QP; Hollingsworth MA; Cox JL; Padussis JC; Foster JM; Vargas LM; Talmadge JE
Cell Immunol; 2021 May; 363():104317. PubMed ID: 33714729
[TBL] [Abstract][Full Text] [Related]
27. CD11b
Nachmany I; Bogoch Y; Sivan A; Amar O; Bondar E; Zohar N; Yakubovsky O; Fainaru O; Klausner JM; Pencovich N
FASEB J; 2019 May; 33(5):5967-5978. PubMed ID: 30730772
[TBL] [Abstract][Full Text] [Related]
28. miR-223 suppresses differentiation of tumor-induced CD11b⁺ Gr1⁺ myeloid-derived suppressor cells from bone marrow cells.
Liu Q; Zhang M; Jiang X; Zhang Z; Dai L; Min S; Wu X; He Q; Liu J; Zhang Y; Zhang Z; Yang R
Int J Cancer; 2011 Dec; 129(11):2662-73. PubMed ID: 21213211
[TBL] [Abstract][Full Text] [Related]
29. Multimodal Intralesional Therapy for Reshaping the Myeloid Compartment of Tumors Resistant to Anti-PD-L1 Therapy via IRF8 Expression.
Patel A; Oba T; Kajihara R; Yokoi T; Abrams SI; Ito F
J Immunol; 2021 Sep; 207(5):1298-1309. PubMed ID: 34362833
[TBL] [Abstract][Full Text] [Related]
30. Metformin induces CD11b+-cell-mediated growth inhibition of an osteosarcoma: implications for metabolic reprogramming of myeloid cells and anti-tumor effects.
Uehara T; Eikawa S; Nishida M; Kunisada Y; Yoshida A; Fujiwara T; Kunisada T; Ozaki T; Udono H
Int Immunol; 2019 Mar; 31(4):187-198. PubMed ID: 30508092
[TBL] [Abstract][Full Text] [Related]
31. Polymorphonuclear myeloid-derived suppressor cells link inflammation and damage response after trauma.
Li X; Liu J; Xing Z; Tang J; Sun H; Zhang X; Lv S; Chen Z; Shi M; Chen M; Zuo S; Lyu X; He Y
J Leukoc Biol; 2021 Dec; 110(6):1143-1161. PubMed ID: 34636072
[TBL] [Abstract][Full Text] [Related]
32. The Voltage-Gated Hv1 H
Cozzolino M; Gyöngyösi A; Korpos E; Gogolak P; Naseem MU; Kállai J; Lanyi A; Panyi G
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047188
[TBL] [Abstract][Full Text] [Related]
33. CCR5 Directs the Mobilization of CD11b
Hawila E; Razon H; Wildbaum G; Blattner C; Sapir Y; Shaked Y; Umansky V; Karin N
Cell Rep; 2017 Nov; 21(8):2212-2222. PubMed ID: 29166611
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic targeting of myeloid-derived suppressor cells involves a novel mechanism mediated by clusterin.
Zhou J; Donatelli SS; Gilvary DL; Tejera MM; Eksioglu EA; Chen X; Coppola D; Wei S; Djeu JY
Sci Rep; 2016 Jul; 6():29521. PubMed ID: 27405665
[TBL] [Abstract][Full Text] [Related]
35. Subsets of myeloid-derived suppressor cells in hepatocellular carcinoma express chemokines and chemokine receptors differentially.
Zhao W; Xu Y; Xu J; Wu D; Zhao B; Yin Z; Wang X
Int Immunopharmacol; 2015 Jun; 26(2):314-21. PubMed ID: 25891236
[TBL] [Abstract][Full Text] [Related]
36. Activated NKT cells facilitated functional switch of myeloid-derived suppressor cells at inflammation sites in fulminant hepatitis mice.
Wu D; Shi Y; Wang C; Chen H; Liu Q; Liu J; Zhang L; Wu Y; Xia D
Immunobiology; 2017 Feb; 222(2):440-449. PubMed ID: 27523745
[TBL] [Abstract][Full Text] [Related]
37. Targeting myeloid-derived suppressor cells in combination with primary mammary tumor resection reduces metastatic growth in the lungs.
Bosiljcic M; Cederberg RA; Hamilton MJ; LePard NE; Harbourne BT; Collier JL; Halvorsen EC; Shi R; Franks SE; Kim AY; Banáth JP; Hamer M; Rossi FM; Bennewith KL
Breast Cancer Res; 2019 Sep; 21(1):103. PubMed ID: 31488209
[TBL] [Abstract][Full Text] [Related]
38. Identification and characterization of B220
Zhang Z; Huang X; Wang E; Huang Y; Yang R
Oncoimmunology; 2021 Apr; 10(1):1912472. PubMed ID: 33948392
[TBL] [Abstract][Full Text] [Related]
39. Alteration of functionality and differentiation directed by changing gene expression patterns in myeloid-derived suppressor cells (MDSCs) in tumor microenvironment and bone marrow through early to terminal phase of tumor progression.
Mahanti K; Saha J; Sarkar D; Pramanik A; Roy Chattopadhyay N; Bhattacharyya S
J Leukoc Biol; 2024 Apr; 115(5):958-984. PubMed ID: 38236200
[TBL] [Abstract][Full Text] [Related]
40. Tumor conditions induce bone marrow expansion of granulocytic, but not monocytic, immunosuppressive leukocytes with increased CXCR2 expression in mice.
Bian Z; Shi L; Venkataramani M; Abdelaal AM; Culpepper C; Kidder K; Liang H; Zen K; Liu Y
Eur J Immunol; 2018 Mar; 48(3):532-542. PubMed ID: 29120053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
